rss
Arch Dis Child Fetal Neonatal Ed 1998;78:F225-F226 doi:10.1136/fn.78.3.F225
  • Original article

Enteral yeast–selenium supplementation in preterm infants

Abstract

AIM To study the bioavailability of selenium enriched yeast in preterm infants living in a low selenium area (Hungary).

METHODS Thirty six preterm infants were randomly assigned to two groups at birth with respect to selenium supplementation. In the supplemented group (n=18) infants received 4.8 mg of selenium enriched yeast containing 5 μg selenium daily.

RESULTS In the supplemented group the serum selenium concentration increased from 36.1(±12.8) μg/l to 43.5 (7.9) μg/l and in the non-supplemented group it decreased from 34.4 (20.4) μg/l to 26.1 (16.6) μg/l from birth in two weeks. No complications or side effects as a result of supplementation were observed.

CONCLUSIONS Selenium enriched yeast is a safe and an effective form of short term enteral selenium supplementation for preterm infants.

Footnotes

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.